2021
Identification and functional characterization of new missense SNPs in the coding region of the TP53 gene
DOFFE, Flora, Vincent CARBONNIER, Manon TISSIER, Bernard LEROY, Isabelle MARTINS et. al.Základní údaje
Originální název
Identification and functional characterization of new missense SNPs in the coding region of the TP53 gene
Autoři
DOFFE, Flora, Vincent CARBONNIER, Manon TISSIER, Bernard LEROY, Isabelle MARTINS, Johanna S. M. MATTSSON, Patrick MICKE, Šárka PAVLOVÁ (203 Česká republika, domácí), Šárka POSPÍŠILOVÁ (203 Česká republika, domácí), Jana ŠMARDOVÁ (203 Česká republika, domácí), Andreas C. JOERGER, Klas G. WIMAN, Guido KROEMER a Thierry SOUSSI
Vydání
Cell Death and Differentiation, London, Springer Nature, 2021, 1350-9047
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30205 Hematology
Stát vydavatele
Velká Británie a Severní Irsko
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 12.067
Kód RIV
RIV/00216224:14740/21:00118820
Organizační jednotka
Středoevropský technologický institut
UT WoS
000594811400001
Klíčová slova anglicky
Genetics research; Tumour-suppressor proteins
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 5. 4. 2022 14:04, Mgr. Pavla Foltynová, Ph.D.
Anotace
V originále
Infrequent and rare genetic variants in the human population vastly outnumber common ones. Although they may contribute significantly to the genetic basis of a disease, these seldom-encountered variants may also be miss-identified as pathogenic if no correct references are available. Somatic and germline TP53 variants are associated with multiple neoplastic diseases, and thus have come to serve as a paradigm for genetic analyses in this setting. We searched 14 independent, globally distributed datasets and recovered TP53 SNPs from 202,767 cancer-free individuals. In our analyses, 19 new missense TP53 SNPs, including five novel variants specific to the Asian population, were recurrently identified in multiple datasets. Using a combination of in silico, functional, structural, and genetic approaches, we showed that none of these variants displayed loss of function compared to the normal TP53 gene. In addition, classification using ACMG criteria suggested that they are all benign. Considered together, our data reveal that the TP53 coding region shows far more polymorphism than previously thought and present high ethnic diversity. They furthermore underline the importance of correctly assessing novel variants in all variant-calling pipelines associated with genetic diagnoses for cancer.
Návaznosti
GA19-15737S, projekt VaV |
|